IVAN
FERNANDEZ BUENO
PROFESOR CONTRATADO DOCTOR
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (22)
2023
-
Ala®sil chemical characterization and toxicity evaluation: an example of the need for the Medical Device Regulation 2017/745
Frontiers in Pharmacology, Vol. 14
-
Safety, biocompatibility, and potential functionality of a new accommodative intraocular lens: An experimental study in rabbits
Heliyon, Vol. 9, Núm. 9
2022
-
Programmed Cell Death and Autophagy in an in vitro Model of Spontaneous Neuroretinal Degeneration
Frontiers in Neuroanatomy, Vol. 16
-
Retinal Neuroprotective Effect of Mesenchymal Stem Cells Secretome Through Modulation of Oxidative Stress, Autophagy, and Programmed Cell Death
Investigative ophthalmology & visual science, Vol. 63, Núm. 4, pp. 27
2021
-
Ex Vivo Model of Spontaneous Neuroretinal Degeneration for Evaluating Stem Cells’ Paracrine Properties
Methods in Molecular Biology (Humana Press Inc.), pp. 125-137
-
Ex-Vivo Method to Quantifiably Evaluate the Staining Effectiveness of Anterior Lens Capsule Dyes
Translational vision science & technology, Vol. 10, Núm. 14, pp. 17
-
Intraocular toxicity caused by MEROCTANE perfluorocarbon liquid
Scientific Reports, Vol. 11, Núm. 1
-
Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome
Neural Regeneration Research, Vol. 16, Núm. 1, pp. 117-118
2020
-
Chemical compounds causing severe acute toxicity in heavy liquids used for intraocular surgery
Regulatory Toxicology and Pharmacology, Vol. 110
-
Human Mesenchymal Stem Cell Secretome Exhibits a Neuroprotective Effect over In Vitro Retinal Photoreceptor Degeneration
Molecular Therapy - Methods and Clinical Development, Vol. 17, pp. 1155-1166
-
Intravitreal stem cell paracrine properties as a potential neuroprotective therapy for retinal photoreceptor neurodegenerative diseases
Neural Regeneration Research, Vol. 15, Núm. 9, pp. 1631-1638
-
Mesenchymal Stem Cell Secretome Enhancement by Nicotinamide and Vasoactive Intestinal Peptide: A New Therapeutic Approach for Retinal Degenerative Diseases
Stem Cells International, Vol. 2020
2019
-
Acute retinal toxicity associated with a mixture of perfluorooctane and perfluorohexyloctane: Failure of another indirect cytotoxicity analysis
British Journal of Ophthalmology, Vol. 103, Núm. 1, pp. 49-54
-
Mesenchymal stem cells provide paracrine neuroprotective resources that delay degeneration of co-cultured organotypic neuroretinal cultures
Experimental Eye Research, Vol. 185
-
Meta-analysis of the rs243865 MMP-2 polymorphism and age-related macular degeneration risk
PLoS ONE, Vol. 14, Núm. 3
-
Reliability and reproducibility of a rodent model of choroidal neovascularization based on the subretinal injection of polyethylene glycol
Molecular Vision, Vol. 25, pp. 194-203
2018
-
Biocompatibility of intravitreal injection of human mesenchymal stem cells in immunocompetent rabbits
Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 256, Núm. 1, pp. 125-134
-
Comparison between direct contact and extract exposure methods for PFO cytotoxicity evaluation
Scientific Reports, Vol. 8, Núm. 1
-
Ocular findings in Zucker Diabetic Fatty rats emphasize the key role of neuroglia degeneration in diabetic retinopathy pathophysiology
Neural Regeneration Research
2017
-
Acute retinal damage after using a toxic perfluoro-octane for vitreo-retinal surgery
Retina, Vol. 37, Núm. 6, pp. 1140-1151